S-777,469
id:
s-777-469-178-18512397
title:
S-777,469
text:
S-777,469 is a drug developed by Shionogi which is a cannabinoid receptor agonist, with 128x selectivity for the CB2 subtype, having a CB2 affinity of 36nM, and a CB1 affinity over 4600nM. In animal studies it showed antipruritic effects, and passed Phase II human trials for the treatment of atopic dermatitis, but development was ultimately not continued further.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/S-777,469
date created:
2020-12-06T01:02:09Z
date modified:
2024-09-04T21:19:12Z
main entity:
{"identifier":"Q27269944","url":"https://www.wikidata.org/entity/Q27269944"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/f/fe/S-777469_structure.png","width":1047,"height":890}
fields total:
13
integrity:
16